ABSTRACT
The experience of performing surgery on the thyroid gland (TG) in 205 patients was generalised, including the use of electric welding of biological tissue technologies (EST) at 95. We used the apparatus for electric welding and high frequency surgical coagulator EK300M1 and EKVZ300 "Patonmed" as well as the original adaptive bipolar coagulation instruments. Operations carried out under endotracheal anesthesia "open" process, completed their stratified overlay nodal joints and vacuumsuction drainage. To assess the effectiveness of EST in thyroid surgery were analyzed during the early postoperative period. The positive impact of technology EST not only on surgical tactics, but also course of the early postoperative period. Recommended use of EST as a standard for surgical interventions on the thyroid.
Subject(s)
Electrocoagulation/methods , Goiter, Nodular/surgery , Receptors, Thyrotropin/deficiency , Thyroid Gland/surgery , Thyroid Neoplasms/surgery , Thyroidectomy/methods , Thyrotoxicosis/surgery , Adult , Aged , Electricity , Electrocoagulation/instrumentation , Esophagus/innervation , Esophagus/pathology , Female , Goiter, Nodular/pathology , Humans , Male , Middle Aged , Parathyroid Glands/innervation , Parathyroid Glands/pathology , Postoperative Complications/pathology , Postoperative Period , Radio Waves , Surgical Wound Infection/diagnosis , Surgical Wound Infection/etiology , Surgical Wound Infection/pathology , Thyroid Gland/pathology , Thyroid Neoplasms/pathology , Thyrotoxicosis/pathologyABSTRACT
Today in the clinic all surgical interventions on endocrinal organs are conducted, using welding technology. Comparative analysis of the operative interventions efficacy, performed applying a standard method (control group) and using welding technology (the main group), was conducted. Performance of operations, using electric welding technologies have permitted to reduce the operative intervention duration by 20 - 30%, the blood loss volume--by 30 - 50%, a postoperative pain syndrome severity and the analgetics expense--by 20%, a postoperative stationary treatment duration--by 1-2 days.
Subject(s)
Blood Loss, Surgical/prevention & control , Electrocoagulation/methods , Endocrine Glands/surgery , Endocrine Surgical Procedures/methods , Endocrine System Diseases/surgery , Hemostatic Techniques/instrumentation , Analgesics/therapeutic use , Electrocoagulation/instrumentation , Endocrine Glands/blood supply , Endocrine Glands/pathology , Endocrine Surgical Procedures/instrumentation , Endocrine System Diseases/pathology , Humans , Operative Time , Pain, Postoperative/drug therapy , Pain, Postoperative/physiopathology , Treatment OutcomeABSTRACT
The results of treatment of 330 children (< 14 years) and adolescents (15-18 years) with thyroid cancer who were operated on at the Institute of Endocrinology after the Chernobyl accident in 1986 were analyzed. The number of young patients increased after 1986 (1981-1985, 9 cases; 1986-1990, 37 cases; 1991-1995, 177 cases; 1996-1998, 116 cases). Most of these children and adolescents were younger than 8 years at the time of the accident (84.2%). More than half of the children (58.1%) lived in areas receiving the highest radiation exposure. These thyroid cancers developed after a short latent period, were more aggressive at presentation, and expressed regional (57.3%) or distant (14.5%) metastasis. Solid papillary cancers were present in 93.1%. Coexisting thyroid conditions were common (thyroid hyperplasia, 25.1%; nodular goiter, 18.8%; chronic thyroiditis, 10.2%). Most patients were treated by total thyroidectomy with intraoperative visualization of recurrent laryngeal nerves and parathyroid glands. When lymph node metastases were identified, a modified neck dissection was performed. Such operations were done in 277 (84.1%) patients. Postoperatively, the patients were treated with radioiodine and thyroid-stimulating hormone suppressive therapy. Postoperative complications included recurrent nerve palsy in 12.3% and permanent hypoparathyroidism in 6%. Operations for local recurrence of cancer were performed in 2.8% cases and for regional metastasis in 4%. The general mortality was 1. 8%. We anticipate that there will be more patients with thyroid cancer during the next few years. Therefore this high risk population for thyroid cancer must be carefully monitored and evaluated during the next several decades.